February 24, 2024
You are here:  Home  >  'KAI'

Amgen to buy KAI for $315M

By   /  Tuesday, April 10th, 2012  /  Latest news  /  Comments Off on Amgen to buy KAI for $315M

Amgen said April 10 that it plans to buy San Francisco-based KAI Pharmaceuticals for $315 million in cash in a deal that would give it worldwide rights to an experimental treatment for patients with chronic kidney disease. Thousand Oaks-based Amgen said the deal would give it worldwide rights, excluding in Japan, to KAI’s lead product, Read More →